CellReady: Our roots in Cell Therapy
Cell-Easy’s story is rooted in the heart of research, and this invaluable experience shapes every action we take to help you bring life-saving treatments forward. Our story started with Human Mesenchymal Stem Cells (hMSCs), adipose-derived. They are remarkable cells, recognized for their natural ability to regenerate tissue, modulate immune responses, and support repair processes. While early autologous trials demonstrated their potential, treating one patient at a time was neither sustainable nor scalable. To efficiently reach more patients, we transformed the autologous process into an allogeneic one and created Cell Ready®, our proprietary GMP-grade allogeneic Human Mesenchymal Stem Cell product. This platform enables standardized, regulatory-compliant, and cost-controlled manufacturing of MSCs.
Key Numbers
x20
Cost reduction vs autologous process
3,5.109
Cells per batch
25
Analytical parameters screened
Why CellReady makes the difference
Our process is based on a xeno-free, scalable, andGMP-compliant manufacturing framework, with a focus on consistency and clinical applicability. Our production process is both shorter in time (14 days), therefore reducing the number of passages of these cells and more efficient in terms of the number of cells obtained and their quality than that used in other studies conducted in the same field. This reduction in cell amplification preserves the immunomodulatory properties of native cells as much as possible while limiting the drift associated with culture processes.
Clinical Programs using CellReady
In collaboration with CHU Toulouse, our Adipose derived Mesenchymal Stem Cells are applied across five clinical programs:
Cell Expertise & Ready-to-Use Cells
Cell Ready® is first and foremost proof of what we can deliver as a cell therapy CDMO: donor qualification, GMP-scale manufacturing, and rigorous quality control, all validated across five active clinical programs. Every capability behind this platform (process development, scale-up, analytical characterization) is the same capability we bring to client programs.
As a direct extension of that expertise, the adipose-derived Mesenchymal Stem Cells produced on this platform are also available to partners, in two formats: Research Use Only (RUO) material for early-stage studies, and GMP-grade batches for clinical use.
Whether you need a cell therapy CDMO to bring that same manufacturing rigor to your own program, or MSCs directly, let’s talk about your project.
Discover more about Cell Easy
About-us
News
Let’s talk about your project
Let’s turn your vision into a reality.
Phone: +33 534 276 550
Address: Cell-Easy SAS, 4 bis avenue Hubert Curien,
31100 Toulouse, France
Mail: info@cell-easy.com
